Example: Heart Attack

Search clinical trials for: Phosphodiesterase 4 Inhibitors

Total 63 results

NCT04108377

Recruiting

Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma

Conditions: Asthma
NCT00250172

Completed

PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram

Conditions: Dosimetry; Healthy
NCT04751071

Recruiting

The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Conditions: Major Depressive Disorder
NCT04658654

Not yet recruiting

Cognitive Effects of Roflumilast in MCI Patients

Conditions: Mild Cognitive Impairment
NCT02037672

Completed

PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome

Conditions: PCOS; Obesity
NCT01433666

Completed

Roflumilast and Cognition

Conditions: Dementia
NCT02187250

Completed

PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome

Conditions: PCOS; Obesity
NCT03351114

Completed

Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

Conditions: Morphea
NCT00668070

Completed

A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831

Conditions: Non-Alcoholic Steatohepatitis
NCT02986321

Completed

A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD

Conditions: Chronic Obstructive Pulmonary Disease
NCT03656666

Recruiting

The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

Conditions: Lichen Planus of Vulva; Female Genital Disease
NCT04214197

Active, not recruiting

Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis

Conditions: Atopic Dermatitis
NCT00549679

Completed

Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients

Conditions: Pulmonary Disease, Chronic Obstructive
NCT04161456

Recruiting

Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata

Conditions: Acne Conglobata
NCT01856764

Completed

Topical Roflumilast in Adults With Atopic Dermatitis

Conditions: Atopic Dermatitis
NCT01031186

Completed

First Time in Human Study

Conditions: Depressive Disorder and Anxiety Disorders
NCT01074502

Terminated

Apremilast in the Treatment of Moderate to Severe Acne

Conditions: Acne
NCT04102241

Active, not recruiting

Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis
NCT01925768

Completed

Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

Conditions: Psoriatic Arthritis
NCT00246935

Completed

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT00242294

Completed

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT00246922

Completed

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

Conditions: Bronchial Asthma
NCT00242307

Completed

Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)

Conditions: Bronchial Asthma
NCT04352595

Recruiting

A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

Conditions: Atopic Dermatitis
NCT01973998

Completed

Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization

Conditions: COPD